Pricing Log in Create free account

Equillium, Inc. (EQ) vs Novogen Limited (KZIA)

Equillium, Inc. and Novogen Limited are both Biotechnology companies. Equillium, Inc. and Novogen Limited are of similar size ($84.6M and $83.7M). Across the 9 metrics below, Novogen Limited leads on 6 and Equillium, Inc. on 3.

Valuation

Metric EQ KZIA Biotechnology median
P/E n/m n/m 8.50
P/S 3.24 n/m 9.71
P/B 2.38 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 1.46 0.64
EV/Sales 2.03 n/m 9.21
Earnings yield (16.81%) (2.98%) (33.15%)
Free cash flow yield (15.09%) 0.00% (25.50%)

Profitability

Metric EQ KZIA Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (58.98%) 0.00% (56.36%)
Return on assets (50.68%) 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric EQ KZIA Biotechnology median
Revenue growth (TTM) 13.89% — 6.02%
EPS growth (last fiscal year) (69.57%) 63.24% 30.26%
Revenue growth, 5-year CAGR — 11.56% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EQ KZIA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 23.40 2.87 4.72
Net debt to EBITDA 1.29 0.30 0.96

Dividend

Metric EQ KZIA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric EQ KZIA Biotechnology median
Market cap 83.70m 84.58m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack